• Something wrong with this record ?

Identification, preparation and UHPLC determination of process-related impurity in zolmitriptan

M. Douša, P. Gibala, S. Rádl, O. Klecán, Z. Mandelová, J. Břicháč, T. Pekárek

. 2012 ; 58 () : 1-6.

Language English Country England, Great Britain

Document type Journal Article

A new impurity was detected and determined using gradient ion-pair UHPLC method with UV detection in zolmitriptan (ZOL). Using MS, NMR and IR study the impurity was identified as (4S,4'S)-4,4'-(2,2'-(4-(dimethylamino)butane-1,1-diyl)bis(3-(2-(dimethylamino) ethyl)-1H-indole-5,2-diyl))bis(methylene)di(oxazolidin-2-one) (ZOL-dimer). The standard of ZOL-dimer was consequently prepared via organic synthesis followed by semipreparative HPLC purification. The UHPLC method was optimized in order to selectively detect and quantify other known and unknown process-related impurities and degradation products of ZOL as well. The presented method which was validated with respect to linearity, accuracy, precision and selectivity has an advantage of a very quick UHPLC chromatographic separation (less than 7 min including re-equilibration time) and therefore is highly suitable for routine analysis of related substances and stability studies of ZOL.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc12024339
003      
CZ-PrNML
005      
20130331211640.0
007      
ta
008      
120815s2012 enk f 000 0#eng||
009      
AR
024    7_
$a 10.1016/j.jpba.2011.08.043 $2 doi
035    __
$a (PubMed)21982522
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Douša, Michal, $d 1968- $7 xx0060122 $u Zentiva, a.s. Praha, U Kabelovny 130, 102 37 Praha 10, Czech Republic. hplc@hplc.cz
245    10
$a Identification, preparation and UHPLC determination of process-related impurity in zolmitriptan / $c M. Douša, P. Gibala, S. Rádl, O. Klecán, Z. Mandelová, J. Břicháč, T. Pekárek
520    9_
$a A new impurity was detected and determined using gradient ion-pair UHPLC method with UV detection in zolmitriptan (ZOL). Using MS, NMR and IR study the impurity was identified as (4S,4'S)-4,4'-(2,2'-(4-(dimethylamino)butane-1,1-diyl)bis(3-(2-(dimethylamino) ethyl)-1H-indole-5,2-diyl))bis(methylene)di(oxazolidin-2-one) (ZOL-dimer). The standard of ZOL-dimer was consequently prepared via organic synthesis followed by semipreparative HPLC purification. The UHPLC method was optimized in order to selectively detect and quantify other known and unknown process-related impurities and degradation products of ZOL as well. The presented method which was validated with respect to linearity, accuracy, precision and selectivity has an advantage of a very quick UHPLC chromatographic separation (less than 7 min including re-equilibration time) and therefore is highly suitable for routine analysis of related substances and stability studies of ZOL.
650    _2
$a techniky syntetické chemie $x metody $7 D060326
650    _2
$a vysokoúčinná kapalinová chromatografie $x metody $7 D002851
650    _2
$a kontaminace léku $7 D004340
650    _2
$a limita detekce $7 D057230
650    _2
$a magnetická rezonanční spektroskopie $x metody $7 D009682
650    _2
$a hmotnostní spektrometrie $x metody $7 D013058
650    _2
$a oxazoly $x izolace a purifikace $7 D010080
650    _2
$a oxazolidinony $x chemie $x izolace a purifikace $7 D023303
650    _2
$a spektrofotometrie infračervená $x metody $7 D013055
650    _2
$a spektrofotometrie ultrafialová $x metody $7 D013056
650    _2
$a tryptaminy $x chemie $x izolace a purifikace $7 D014363
655    _2
$a časopisecké články $7 D016428
700    1_
$a Gibala, Petr
700    1_
$a Rádl, Stanislav, $7 jx20061013029 $d 1951-
700    1_
$a Klecán, Ondřej, $d 1973- $7 xx0125452
700    1#
$a Mandelová, Zuzana. $7 _AN034059
700    1#
$a Břicháč, Jiří. $7 xx0194030
700    1_
$a Pekárek, Tomáš
773    0_
$w MED00002894 $t Journal of pharmaceutical and biomedical analysis $x 1873-264X $g Roč. 58(2012), s. 1-6
856    41
$u https://pubmed.ncbi.nlm.nih.gov/21982522 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y m
990    __
$a 20120815 $b ABA008
991    __
$a 20130331211924 $b ABA008
999    __
$a ok $b bmc $g 946487 $s 781667
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2012 $b 58 $d 1-6 $i 1873-264X $m Journal of pharmaceutical and biomedical analysis $n J Pharm Biomed Anal $x MED00002894
LZP    __
$a Pubmed-20120815/12/02

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...